Brief: Myriad Genetics Announces Third Patent Granted For Molecular Residual Disease (Mrd) With Early Priority Date
01/10/2024 21:57
Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS ANNOUNCES THIRD PATENT GRANTED FOR
MOLECULAR
RESIDUAL DISEASE (MRD) WITH EARLY PRIORITY DATE
* MYRIAD GENETICS INC - CONTINUES DEVELOPMENT OF PRECISE MRD
ASSAY
Source text for Eikon: ID:nGNXc2q1sB
Further company coverage: MYGN.O
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple